Gebruikersprofielen voor "Siegel, D. "

Donald Siegel

- Geverifieerd e-mailadres voor asu.edu - Geciteerd door 84160

David Siegel

- Geverifieerd e-mailadres voor hmhn.org - Geciteerd door 41848

David A. Siegel

- Geverifieerd e-mailadres voor icess.ucsb.edu - Geciteerd door 39898

NAD (P) H: quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms

D Ross, JK Kepa, SL Winski, HD Beall, A Anwar… - Chemico-biological …, 2000 - Elsevier
NAD(P)H:quinone oxidoreductase 1 (NQO1) is an obligate two-electron reductase that is
involved in chemoprotection and can also bioactivate certain antitumor quinones. This review …

Initiation and use of propranolol for infantile hemangioma: report of a consensus conference

BA Drolet, PC Frommelt, SL Chamlin, A Haggstrom… - …, 2013 - publications.aap.org
Infantile hemangiomas (IHs) are common neoplasms composed of proliferating endothelial-like
cells. Despite the relative frequency of IH and the potential severity of complications, …

Disorganized attachment in infancy: A review of the phenomenon and its implications for clinicians and policy-makers

P Granqvist, LA Sroufe, M Dozier, E Hesse… - Attachment & human …, 2017 - Taylor & Francis
Disorganized/Disoriented (D) attachment has seen widespread interest from policy makers,
practitioners, and clinicians in recent years. However, some of this interest seems to have …

[BOEK][B] Siegel/mindful Brain: Reflection And Attunement In The Cultivation Of Well Being

DJ Siegel - 2007 - books.google.com
A new framework for maintaining mental health and well-being. From the author of the
internationally-acclaimed best-selling text The Developing Mind, and esteemed leader and …

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma

S Jagannath, B Barlogie, J Berenson… - British journal of …, 2004 - Wiley Online Library
In a phase 2 open‐label study of the novel proteasome inhibitor bortezomib, 54 patients
with multiple myeloma who had relapsed after or were refractory to frontline therapy were …

Total therapy with tandem transplants for newly diagnosed multiple myeloma

B Barlogie, S Jagannath, KR Desikan… - Blood, The Journal …, 1999 - ashpublications.org
Between August 1990 and August 1995, 231 patients (median age 51, 53% Durie-Salmon
stage III, median serum β-2-microglobulin 3.1 g/L, median C-reactive protein 4 g/L) with …

An empirical analysis of the strategic use of corporate social responsibility

DS Siegel, DF Vitaliano - Journal of Economics & Management …, 2007 - Wiley Online Library
Recent theories of the strategic use of corporate social responsibility (CSR) emphasize the
role of information asymmetry and how CSR is likely to be incorporated into a firm's product …

[HTML][HTML] A phase 2 study of bortezomib in relapsed, refractory myeloma

PG Richardson, B Barlogie, J Berenson… - … England Journal of …, 2003 - Mass Medical Soc
Background Bortezomib, a boronic acid dipeptide, is a novel proteasome inhibitor that has
been shown in preclinical and phase 1 studies to have antimyeloma activity. Methods In this …

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

TK Warren, R Jordan, MK Lo, AS Ray, RL Mackman… - Nature, 2016 - nature.com
The most recent Ebola virus outbreak in West Africa, which was unprecedented in the number
of cases and fatalities, geographic distribution, and number of nations affected, highlights …

Influence of mesoscale eddies on new production in the Sargasso Sea

DJ McGillicuddy Jr, AR Robinson, DA Siegel… - Nature, 1998 - nature.com
It is problematic that geochemical estimates of new production — that fraction of total primary
production in surface waters fuelled by externally supplied nutrients — in oligotrophic …